Nifty

:

23587.50

Sensex

:

78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Login

Nifty
Sensex

:
:

23587.50
78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Aarti Pharmalabs Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 543748 | NSE: AARTIPHARM

Watchlist

NSE BSE

570.95

20-Dec-2024

Open
High
Low
Previous Close

568.00
582.50
565.55
571.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

277645
1590.39
721.70
399.55

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,171.12
22.67
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,497.27
0.53%
2.79

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
15.58

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
13.47

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
21.06

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 22.14
P/E Ratio 28.34
Revenue 1468
EBITDA 346
Net Income 201
ROA 9.4
P/Bk Ratio 3.51
ROE 13.11
FCFF 46.61
FCFF Yield 0.79

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 377.29 356.14 5.94% 393.49 358.14 9.87% 414.82 374.27 10.83% 373.03 359.33 3.81%
Expenses 292.52 282.34 3.61% 309.83 281.40 10.10% 307.48 297.47 3.37% 284.75 286.77 -0.70%
EBITDA 84.77 73.80 14.86% 83.65 76.74 9.00% 107.34 76.80 39.77% 88.28 72.56 21.66%
EBIDTM 22.47% 20.72% 21.26% 21.43% 25.88% 20.52% 23.67% 20.19%
Other Income 2.95 0.00 0 2.11 4.86 -56.58% 5.68 0.00 0 0.20 0.04 400.00%
Interest 5.39 3.82 41.10% 4.25 4.03 5.46% 4.42 5.80 -23.79% 4.10 5.12 -19.92%
Depreciation 18.89 16.32 15.75% 18.29 15.44 18.46% 17.32 14.25 21.54% 16.94 14.56 16.35%
PBT 63.43 53.67 18.19% 63.23 62.13 1.77% 91.28 56.75 60.85% 67.44 52.92 27.44%
Tax 15.60 11.86 31.53% 16.08 14.50 10.90% 28.26 16.76 68.62% 19.25 14.38 33.87%
PAT 47.84 41.81 14.42% 47.14 47.63 -1.03% 63.02 39.99 57.59% 48.19 38.54 25.04%
PATM 12.68% 11.74% 11.98% 13.30% 15.19% 10.68% 12.92% 10.73%
EPS 5.28 4.61 14.53% 5.20 5.26 -1.14% 6.96 4.41 57.82% 5.32 4.25 25.18%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 458.03 439.80 4.15% 555.49 458.36 21.19% 505.77 485.06 4.27% 448.69 471.62 -4.86%
Expenses 364.35 351.81 3.56% 459.03 373.49 22.90% 388.25 405.07 -4.15% 353.01 385.38 -8.40%
EBITDA 93.67 87.99 6.46% 96.46 84.87 13.66% 117.52 79.99 46.92% 95.68 86.24 10.95%
EBIDTM 20.45% 20.01% 17.36% 18.52% 23.24% 16.49% 21.32% 18.29%
Other Income 4.48 0.99 352.53% 2.22 0.48 362.50% 2.03 0.74 174.32% 1.39 0.29 379.31%
Interest 5.51 3.89 41.65% 4.83 4.17 15.83% 4.68 5.94 -21.21% 4.48 5.25 -14.67%
Depreciation 20.88 18.14 15.10% 20.17 17.20 17.27% 19.12 15.95 19.87% 18.77 16.25 15.51%
PBT 71.77 66.95 7.20% 73.68 63.98 15.16% 95.75 58.84 62.73% 73.82 65.03 13.52%
Tax 17.14 15.14 13.21% 18.22 16.88 7.94% 30.50 15.97 90.98% 21.06 17.34 21.45%
PAT 54.62 51.80 5.44% 55.45 47.09 17.75% 65.25 42.87 52.20% 52.76 47.69 10.63%
PATM 11.93% 11.78% 9.98% 10.27% 12.90% 8.84% 11.76% 10.11%
EPS 6.03 5.72 5.42% 6.12 5.20 17.69% 7.20 4.73 52.22% 5.82 5.26 10.65%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 1,558.63 1,502.13 1,511.25 941.02 Net Sales Growth 7.65% -0.60% 60.60% Cost Of Goods Sold 755.81 751.97 817.93 451.66 Gross Profit 802.82 750.16 693.32 489.36 GP Margin 51.51% 49.94% 45.88% 52.00% Total Expenditure 1,194.58 1,155.97 1,202.91 761.24 Power & Fuel Cost - 82.92 74.22 69.73 % Of Sales - 5.52% 4.91% 7.41% Employee Cost - 120.15 113.92 79.98 % Of Sales - 8.00% 7.54% 8.50% Manufacturing Exp. - 99.70 96.20 132.62 % Of Sales - 6.64% 6.37% 14.09% General & Admin Exp. - 28.39 29.30 6.98 % Of Sales - 1.89% 1.94% 0.74% Selling & Distn. Exp. - 49.19 48.54 20.25 % Of Sales - 3.27% 3.21% 2.15% Miscellaneous Exp. - 23.65 22.80 0.01 % Of Sales - 1.57% 1.51% 0.00% EBITDA 364.04 346.16 308.34 179.78 EBITDA Margin 23.36% 23.04% 20.40% 19.10% Other Income 10.94 11.01 1.28 2.51 Interest 18.16 16.63 20.49 11.34 Depreciation 71.44 66.01 55.77 37.23 PBT 285.38 274.52 233.36 133.73 Tax 79.19 73.87 61.63 27.00 Tax Rate 27.75% 26.91% 26.41% 20.19% PAT 206.19 200.65 171.73 106.73 PAT before Minority Interest 206.19 200.65 171.73 106.73 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 13.23% 13.36% 11.36% 11.34% PAT Growth 22.75% 16.84% 60.90% EPS 22.76 22.15 18.95 11.78

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 1,967.98 1,852.61 1,945.23 1,199.94 Net Sales Growth 6.10% -4.76% 62.11% Cost Of Goods Sold 1,071.37 1,020.71 1,169.76 637.67 Gross Profit 896.61 831.89 775.48 562.27 GP Margin 45.56% 44.90% 39.87% 46.86% Total Expenditure 1,564.64 1,466.56 1,603.18 994.67 Power & Fuel Cost - 84.03 75.10 90.00 % Of Sales - 4.54% 3.86% 7.50% Employee Cost - 128.03 121.32 85.20 % Of Sales - 6.91% 6.24% 7.10% Manufacturing Exp. - 107.30 98.78 145.95 % Of Sales - 5.79% 5.08% 12.16% General & Admin Exp. - 30.08 30.20 8.13 % Of Sales - 1.62% 1.55% 0.68% Selling & Distn. Exp. - 68.88 74.83 27.38 % Of Sales - 3.72% 3.85% 2.28% Miscellaneous Exp. - 27.53 33.20 0.34 % Of Sales - 1.49% 1.71% 0.03% EBITDA 403.33 386.05 342.05 205.27 EBITDA Margin 20.49% 20.84% 17.58% 17.11% Other Income 10.12 4.89 2.32 4.19 Interest 19.50 17.21 21.05 11.96 Depreciation 78.94 73.24 62.54 42.12 PBT 315.02 300.49 260.77 155.38 Tax 86.92 83.59 67.28 33.13 Tax Rate 27.59% 27.82% 25.80% 21.32% PAT 228.08 216.90 193.49 122.25 PAT before Minority Interest 228.08 216.90 193.49 122.25 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 11.59% 11.71% 9.95% 10.19% PAT Growth 20.39% 12.10% 58.27% EPS 25.17 23.94 21.36 13.49

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,621.46 1,438.58 1,284.28 Share Capital 45.31 45.31 0.25 Total Reserves 1,575.92 1,393.27 1,238.71 Non-Current Liabilities 119.87 74.04 60.88 Secured Loans 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 5.28 4.66 0.00 Current Liabilities 555.58 463.75 481.67 Trade Payables 254.79 212.50 131.61 Other Current Liabilities 43.76 36.20 8.98 Short Term Borrowings 250.80 206.71 324.62 Short Term Provisions 6.24 8.33 16.46 Total Liabilities 2,296.91 1,976.37 1,826.83 Net Block 953.33 848.40 701.12 Gross Block 1,472.15 1,303.76 1,100.71 Accumulated Depreciation 518.82 455.37 399.59 Non Current Assets 1,162.85 1,010.15 936.56 Capital Work in Progress 136.92 101.90 187.37 Non Current Investment 43.83 42.67 39.87 Long Term Loans & Adv. 28.77 17.18 8.21 Other Non Current Assets 0.00 0.00 0.00 Current Assets 1,134.06 966.22 890.27 Current Investments 17.83 12.81 0.00 Inventories 582.15 537.68 444.38 Sundry Debtors 448.82 371.67 304.22 Cash & Bank 4.43 0.37 56.50 Other Current Assets 80.83 7.18 11.53 Short Term Loans & Adv. 66.86 36.51 73.65 Net Current Assets 578.48 502.47 408.60 Total Assets 2,296.91 1,976.37 1,826.83

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,757.04 1,558.49 1,386.48 Share Capital 45.31 45.31 0.25 Total Reserves 1,711.50 1,513.17 1,340.91 Non-Current Liabilities 130.68 84.91 72.76 Secured Loans 0.04 0.18 0.55 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 6.06 5.36 0.00 Current Liabilities 694.39 600.62 580.67 Trade Payables 378.32 339.50 214.59 Other Current Liabilities 45.84 38.33 11.89 Short Term Borrowings 263.92 213.78 337.73 Short Term Provisions 6.31 9.01 16.46 Total Liabilities 2,582.11 2,244.02 2,039.91 Net Block 1,033.33 925.84 782.09 Gross Block 1,609.29 1,431.25 1,225.00 Accumulated Depreciation 575.96 505.41 442.90 Non Current Assets 1,236.46 1,081.02 1,011.75 Capital Work in Progress 136.92 101.87 187.37 Non Current Investment 36.78 35.52 32.23 Long Term Loans & Adv. 29.44 17.78 10.07 Other Non Current Assets 0.00 0.00 0.00 Current Assets 1,345.64 1,163.01 1,028.15 Current Investments 70.39 50.99 0.00 Inventories 642.86 602.04 475.45 Sundry Debtors 519.34 450.10 376.66 Cash & Bank 24.07 12.19 83.27 Other Current Assets 88.98 7.70 10.74 Short Term Loans & Adv. 71.97 39.98 82.03 Net Current Assets 651.25 562.38 447.48 Total Assets 2,582.10 2,244.03 2,039.90

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity 183.69 215.88 -64.84 PBT 274.52 233.36 133.73 Adjustment 80.71 76.87 46.08 Changes in Working Capital -124.55 -37.61 -229.65 Cash after chg. in Working capital 230.68 272.61 -49.84 Interest Paid 0.00 0.00 0.00 Tax Paid -46.99 -56.73 -15.00 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -184.40 -115.55 -133.54 Net Fixed Assets -203.41 -117.58 Net Investments -6.18 -15.61 Others 25.19 17.64 Cash from Financing Activity 4.40 -156.53 254.63 Net Cash Inflow / Outflow 3.70 -56.20 56.25 Opening Cash & Equivalents 0.30 56.50 0.25 Closing Cash & Equivalent 4.00 0.30 56.50

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity 216.35 250.12 -43.70 PBT 300.49 260.77 155.38 Adjustment 94.65 83.35 52.41 Changes in Working Capital -121.85 -31.63 -230.36 Cash after chg. in Working capital 273.29 312.50 -22.57 Interest Paid 0.00 0.00 0.00 Tax Paid -56.94 -62.38 -21.13 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -214.56 -157.80 -138.74 Net Fixed Assets -203.41 -117.58 Net Investments -6.18 -15.61 Others -4.97 -24.61 Cash from Financing Activity 9.72 -163.46 260.38 Net Cash Inflow / Outflow 11.51 -71.15 77.94 Opening Cash & Equivalents 12.12 83.27 5.33 Closing Cash & Equivalent 23.63 12.12 83.27

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 178.89 158.74 49558.52 ROA 9.39% 9.03% 11.68% ROE 13.11% 12.83% 17.23% ROCE 16.55% 15.60% 18.03% Fixed Asset Turnover 1.08 1.26 0.85 Receivable days 99.68 81.62 118.00 Inventory Days 136.05 118.59 172.36 Payable days 113.41 76.78 53.18 Cash Conversion Cycle 122.33 123.44 237.18 Total Debt/Equity 0.15 0.14 0.26 Interest Cover 17.50 12.39 12.79

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 193.85 171.97 53646.60 ROA 8.99% 9.03% 11.98% ROE 13.08% 13.35% 18.23% ROCE 16.75% 16.11% 19.40% Fixed Asset Turnover 1.22 1.46 0.98 Receivable days 95.50 77.57 114.57 Inventory Days 122.63 101.09 144.62 Payable days 128.34 86.45 61.41 Cash Conversion Cycle 89.79 92.21 197.78 Total Debt/Equity 0.15 0.14 0.25 Interest Cover 18.46 13.39 13.99

Top Investors:

life insurance corporation of india

quant mutual fund - quant small cap fund

ntasain discovery master fund

nishant pradip shah

morgan stanley investment funds emerging leaders equity fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Aarti Pharmalabs - Quarterly Results
28th Oct 2024, 16:02 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback